logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Jilin Changlong Pharmaceutical (08049.HK) subscribed for 50 million yuan Industrial and Commercial Bank financial products.

date
21/08/2025
Zhtng Cijng APP Xn, Jln Chnglng Yoy (08049.HK) fb gnggo, y 2025 nin 8 yu 21 r, gngs xing Zhnggu Gngshng Ynhng rngu lci chnpn, jingjn rnmnb 5,000 wn yun.
Latest
1 m ago
Cloud Coal Energy: Net loss of 163 million yuan in the first half of 2025.
1 m ago
Jiangxi Provincial Party Secretary Yin Hong meets with the Chairman of the Board of Directors of Singapore Fengyi International Group, Guo Kongfeng, and his delegation.
1 m ago
Ubtech once again took the lead in leading two national technical standards for humanoid robots.
2 m ago
On August 21, Concord Medical Services Holdings Limited (02120.HK) spent HK$1.2775 million to repurchase 120,900 shares.
4 m ago
According to the Hong Kong Stock Exchange documents, Tianchen Biopharmaceutical Co., Ltd. - B has submitted its listing application to the Hong Kong Stock Exchange.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.